EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 327 filers reported holding EXELIXIS INC in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $134,000 | -11.8% | 6,453 | -3.7% | 0.04% | +25.8% |
| Q1 2022 | $152,000 | +24.6% | 6,701 | +0.4% | 0.03% | +29.2% |
| Q4 2021 | $122,000 | +2.5% | 6,676 | +18.6% | 0.02% | -7.7% |
| Q3 2021 | $119,000 | +22.7% | 5,627 | 0.0% | 0.03% | +23.8% |
| Q2 2021 | $97,000 | -28.1% | 5,627 | -5.6% | 0.02% | -34.4% |
| Q1 2021 | $135,000 | -10.6% | 5,960 | -20.9% | 0.03% | -5.9% |
| Q4 2020 | $151,000 | -59.7% | 7,537 | -65.4% | 0.03% | -76.6% |
| Q1 2020 | $375,000 | -0.8% | 21,799 | +1.6% | 0.14% | +30.6% |
| Q4 2019 | $378,000 | +157.1% | 21,458 | +158.6% | 0.11% | +109.4% |
| Q3 2019 | $147,000 | -23.8% | 8,299 | -8.0% | 0.05% | -11.7% |
| Q2 2019 | $193,000 | – | 9,017 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |